Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

WHAT'S NEW

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Dec 21 2021

Full Issue

Novavax Covid Shot Approved For Emergency Use By EU, WHO

Axios reports that the approval of Novavax will likely be a boon for vaccinating the developing world — the shot is highly effective against covid and can be stored at normal refrigerator temperatures. Also in the news: Japan's covid case count falls and fake covid health passes in France.

Axios: WHO And EU Clear Novavax, Adding Another Option To Vaccine Arsenal 

The WHO and EU have now cleared Novavax’s COVID-19 vaccine for emergency use, adding another shot to the global arsenal. The biggest impact will likely be in the developing world as the American company has promised over 1 billion doses to the WHO-backed COVAX initiative. The vaccine can be stored at normal refrigerator temperatures and proved highly effective in clinical trials. (Lawler, 12/20)

Reuters: As Omicron Threatens A Global Surge, Some Countries Shorten COVID-19 Booster Timelines 

A growing number of countries are reducing the wait time for COVID-19 vaccine boosters from six months to as few as three in a bid to ward off a new surge in infections from the Omicron variant. They are reacting to early evidence suggesting that Omicron is spreading faster than its predecessor, Delta, and is more likely to infect people who were vaccinated or had COVID in the past. Some scientists, however, say that giving boosters too soon could compromise the level of longer-term vaccine protection. (Beasley, 12/20)

NPR: Japan Tries To Solve The Riddle Of Its Dramatic Drop In COVID Cases

In mid-August, not long after the Tokyo Olympics had wrapped up, the situation in Japan looked grim to Dr. Hideaki Oka, an infectious disease expert at the Saitama Medical University Hospital outside Tokyo. As he treated COVID-19 patients at his hospital, Japan was in the grip of a fifth wave of infections. New cases nationwide had surged to around 25,000 a day, and the country's medical system was being stretched to its limits. By late September, cases had plunged, and Oka is now getting a respite, of sorts. "We have had zero COVID patients in our hospital for two months straight," he explains, "so we've been able to concentrate on general medicine just as in pre-COVID times." (Kuhn, 12/20)

The Washington Post: French Police Find 182,000 Fake Covid Health Passes

French police have uncovered 182,000 fake health passes since the documents were introduced this summer in a bid to control the spread of the coronavirus. President Emmanuel Macron introduced the official passes in July, and they have become necessary to gain access to numerous venues, including bars, restaurants and many long-distance trains. They can be obtained through vaccination, recovery from covid-19 or a recent negative test. (Pannett, 12/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF